Specialized Bacteriocin Compositions for Niche Environments

Publication ID: 24-11857606_0009_PTD
Published: October 28, 2025
Category:Specialized Variations & Niche Solutions

Legal Citation

pr1or.art Inc., “Specialized Bacteriocin Compositions for Niche Environments,” Published Technical Disclosure No. 24-11857606_0009_PTD, Published October 28, 2025, available at https://archive.pr1or.art/24-11857606_0009_PTD
This technical disclosure describes improvements that would be readily apparent to a Person Having Ordinary Skill In The Art (PHOSITA) when considered in combination with the foundational architecture disclosed in U.S. Patent No. 11,857,606.

Summary of the Inventive Concept

The present inventive concept provides specialized bacteriocin compositions and methods adapted for specific, narrow market or unique operational environments, such as high-security needs, disaster relief, or extreme weather conditions.

Background and Problem Solved

The original patent disclosed therapeutic bacteriocins for reducing growth of microbial colonies. However, the patent did not address the specific challenges of utilizing bacteriocins in extreme or unique environments. The present inventive concept solves this problem by adapting the bacteriocin compositions and methods for these specialized settings.

Detailed Description of the Inventive Concept

The inventive concept comprises bacteriocin compositions with receptor-mediated translocation domains, cargo domains, and labeling domains tailored for specific niches. For example, the composition for high-temperature environments includes a cargo domain that degrades peptidoglycan, while the composition for disaster relief settings features a labeling domain that targets Gram-negative bacteria. The inventive concept also encompasses methods for administering these compositions in these specialized environments.

Novelty and Inventive Step

The new claims introduce novel bacteriocin compositions and methods that are specifically adapted for unique operational environments, which is not addressed in the original patent. The inventive step lies in the recognition of the need for specialized bacteriocin compositions and methods for these niches and the development of tailored solutions.

Alternative Embodiments and Variations

Alternative embodiments of the inventive concept could include bacteriocin compositions with different receptor-mediated translocation domains, cargo domains, or labeling domains for various niche environments. Additionally, the inventive concept could be implemented using different administration methods, such as aerosol delivery or oral administration.

Potential Commercial Applications and Market

The inventive concept has significant commercial potential in industries such as biotechnology, pharmaceuticals, and healthcare, particularly in areas with high-security needs, disaster relief efforts, or extreme weather conditions. The target market includes hospitals, research institutions, and government agencies.

CPC Classifications

SectionClassGroup
A A61 A61K38/43
A A01 A01N63/10
A A01 A01N63/50
C C07 C07K14/21
C C07 C07K14/26
C C12 C12N9/2462

Original Patent Information

Patent NumberUS 11,857,606
TitleTherapeutic bacteriocins
Assignee(s)BACTOCLEAR HOLDINGS PTE. LTD.